Table 3 Study outcomes
Population (n = 187) | SARS-CoV-2 negative (n = 52) | SARS-CoV-2 positive (n = 135) | P-value | |
|---|---|---|---|---|
Major respiratory complications | 91 (48.7) | 21 (40.4) | 70 (51.9) | 0.21 |
Post-operative O2 requirement | 51 (28.5) | 9 (18.4) | 42 (32.3) | 0.10 |
Curative NIV before h6 | 3 (2.2) | 0 (0.0) | 3 (2.9) | |
HFO before h6 | 1 (0.8) | 0 (0.0) | 1 (1.1) | 0.66 |
Unplanned reintubation before h6 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1.00 |
Pneumonia up to d7 | 39 (21.8) | 9 (17.3) | 30 (23.6) | 0.47 |
ICU admission | ||||
Immediately after surgery | 41 (22.4) | 17 (33.3) | 24 (18.2) | 0.02 |
Up to 7-day | 67 (35.8) | 19 (36.5) | 48 (35.6) | 1.00 |
AKI, AKIN | ||||
Class ≥ 2 | 24 (13.8) | 6 (12.2) | 18 (14.5) | 0.45 |
Discharge alive | ||||
Up to 7-day | 52 (28.1) | 21 (40.4) | 31 (23.3) | 0.03 |
Up to 28- days | 94 (64.8) | 32 (76.2) | 62 (60.2) | 0.10 |
In-hospital death | ||||
Up to 7-day | 15 (8.1) | 3 (5.8) | 12 (9.0) | 0.68 |
Up to 28- days | 18 (13.1) | 3 (8.1) | 15 (15.0) | 0.44 |